A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease
Become involved in the GATEWAY Clinical Trial (Gene Therapy for Wilson's Disease)
Summary
- Eligibility
- for people ages 18-65 (full criteria)
- Location
- at Sacramento, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Valentina Medici, Dr
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Davis
- Valentina Medici, Dr
Professor, MED: Int Med Gastroenterology, School of Medicine. Authored (or co-authored) 132 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Vivet Therapeutics SAS
- Links
- Sign up for this study
- ID
- NCT04537377
- Phase
- Phase 1/2 Wilson's Disease Research Study
- Study Type
- Interventional
- Participants
- Expecting 16 study participants
- Last Updated